Clinical Trial Update: Efficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficiency and safety of Ingaron (Interferon-gamma human recombinant) for chronic prostatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostatitis

Drugs mentioned

• Ingaron (Interferon-gamma)

Snippet

Sponsor: SPP Pharmaclon Ltd. | Conditions: Chronic Prostatitis | Phase 3 | Status: COMPLETED